These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32105278)

  • 1. [Apathy syndrome in depressed patients previously treated with selective serotonin reuptake inhibitors].
    Petrova NN; Markin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):111-117. PubMed ID: 32105278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants for Depression, Apathy, and Gait Instability in Parkinson's Disease: A Multicenter Randomized Study.
    Takahashi M; Tabu H; Ozaki A; Hamano T; Takeshima T;
    Intern Med; 2019 Feb; 58(3):361-368. PubMed ID: 30146591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.
    Marangell LB; Johnson CR; Kertz B; Zboyan HA; Martinez JM
    J Clin Psychiatry; 2002 May; 63(5):391-5. PubMed ID: 12019662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study.
    Padala PR; Padala KP; Majagi AS; Garner KK; Dennis RA; Sullivan DH
    Medicine (Baltimore); 2020 Aug; 99(33):e21497. PubMed ID: 32871995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of SSRI-associated apathy syndrome by discontinuation of therapy.
    Padala PR; Padala KP; Monga V; Ramirez DA; Sullivan DH
    Ann Pharmacother; 2012 Mar; 46(3):e8. PubMed ID: 22353235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.
    Yuen GS; Gunning FM; Woods E; Klimstra SA; Hoptman MJ; Alexopoulos GS
    J Affect Disord; 2014 Sep; 166():179-86. PubMed ID: 25012429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for treating depression using non-selective serotonin reuptake inhibitors.
    Withersty DJ; Vanin JR
    W V Med J; 1999; 95(1):20-3. PubMed ID: 9949692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Panic and depression: early diagnosis of patients at risk, early treatment with an SSRI (Selective Serotonin Reuptake Inhibitor)].
    Psychiatr Prax; 1997 Sep; 24(5 Suppl):1-4. PubMed ID: 9361703
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
    Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB
    J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease?
    Zahodne LB; Bernal-Pacheco O; Bowers D; Ward H; Oyama G; Limotai N; Velez-Lago F; Rodriguez RL; Malaty I; McFarland NR; Okun MS
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):326-30. PubMed ID: 23037646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks].
    Ebert D
    Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents.
    Axelson DA; Perel JM; Birmaher B; Rudolph G; Nuss S; Yurasits L; Bridge J; Brent DA
    Am J Psychiatry; 2005 Apr; 162(4):802-4. PubMed ID: 15800159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating depression with selective serotonin reuptake inhibitors: a practical approach.
    Sampson SM
    Mayo Clin Proc; 2001 Jul; 76(7):739-44. PubMed ID: 11444407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
    Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review.
    Regan KL
    J Cardiovasc Nurs; 2008; 23(6):489-96. PubMed ID: 18953212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.